PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF TOXOPLASMOSIS, COMPRISING ANTI-NON-SMALL CELL LUNG CANCER AGENT AS ACTIVE INGREDIENT

摘要

The present invention relates to a pharmaceutical composition, a veterinary composition, and an antiprotozoal adjuvant agent for prevention or treatment of toxoplasmosis, the pharmaceutical composition, the veterinary composition, and the antiprotozoal adjuvant agent each comprising an anti-non-small cell lung cancer agent as an active ingredient. The present invention also relates to a method for preventing or treating toxoplasmosis.